Peptide COA Checks for Researchers: Purity Alone Is Not Proof
A peptide documentation page passes a first screen only if it shows key evidence: mass spectrometry identity evidence, HPLC purity paired with a net peptide content value, and a lot number and test date that match your vial. A COA for a different lot, missing MS data, or an anonymous lab is an immediate fail. Good pages also name their reference standards, such as USP materials or NIST SRMs. All peptides we discuss are research compounds.
TL;DR:
A parent ion cannot confirm residue order or terminal chemistry, so compare the full modified sequence’s expected mass with annotated MS/MS fragment coverage.
HPLC purity measures material that absorbs ultraviolet light, not salts, water, sterility, or endotoxin; request net content and contamination tests when the experiment requires them.
A release date does not establish shelf life after shipping or repeated handling; ask for stability results tied to stated temperatures, containers, and test intervals.
If methods or spectra are missing, request raw chromatography, mass spectrometry, and UV files, annotated MS/MS, the SOP, and system suitability records from the laboratory.
Table of Contents
What does a peptide documentation page legitimately show?
A certificate of analysis is a bundle of claims, and each claim maps to one question: is this the right molecule, how clean is it, how much peptide is actually in the vial, and can the document be tied to your batch? Read each element for what it proves, and for what it does not.
HPLC-UV chromatogram and percent purity. The trace shows how much of the UV-absorbing material elutes as the main peak. Without the gradient, column, wavelength, and integration notes, a purity percentage is a number you cannot reproduce or challenge.
MS or MS/MS panels. Look for the observed m/z, the calculated mass, and ideally annotated fragments that tie peaks to the sequence. A bare “mass confirmed” line is a statement, not evidence.
Net peptide content. Lyophilized peptide carries counter-ions (often trifluoroacetate or acetate), residual water, and salts. The labeled mass on a vial is rarely the peptide mass alone, which is why content is reported separately from purity.
Laboratory metadata. Lot number, test date, instrument or method ID, and a lab contact let anyone else trace the result.
Our Peptide Certificate of Analysis Guide walks through these fields in more detail.
What do COAs usually leave out?
Even a well-built COA answers a narrow set of questions. It describes one lot, at one point in time, by the methods listed. Several things researchers assume are covered often are not.
Sterility and endotoxin. Unless the document lists a sterility or endotoxin assay with a method and result, assume neither was tested. Purity by HPLC says nothing about microbial or pyrogenic contamination.
Stability under your conditions. A COA is a release snapshot. It does not predict how the material behaves after transit, repeated handling, or storage in your lab. Our article on peptide stability, storage, and handling covers why.
Method detail. A chromatogram printed without method information limits what you can conclude. You cannot tell whether a co-eluting impurity would have been resolved by a different gradient.
Other lots. A COA never vouches for the next batch. That is why a lot-matched document matters more than an impressive-looking generic one.
Treat the absence of a test as information. If your experiment depends on sterility or defined stability, request that data explicitly rather than inferring it.
Which fields should you check, in order?
Work through the document the same way every time. A fixed order keeps you from being charmed by a clean-looking chromatogram before confirming the page belongs to your sample.
Lot or batch number and test date. Confirm an exact character-for-character match with your vial or shipment paperwork.
Sample name and expected molecular weight. Compute the expected mass from the sequence yourself, then compare it with the MS result and any sequence annotation.
HPLC chromatogram and method summary. Check retention times, gradient or method ID, detector wavelength, and integration notes. Look for a full baseline, not a cropped window around the main peak.
MS spectra and annotation. Peaks should be tied to the sequence, ideally with MS/MS fragment coverage rather than a single parent ion.
Assay or net peptide content. Note the method (mass balance, amino acid analysis, or qNMR) and whether water and counter-ion corrections are shown.
Laboratory identity and contact. A named lab, a way to reach it, and any accreditation or system suitability statement.
What are the red flags, and how do you verify quickly?
Most problem documents fail in predictable ways. Spot them early, then escalate with specific requests instead of vague complaints.
A lot number that does not match your vial, or no lot number at all.
A “representative” or “typical” COA offered in place of a batch-specific one.
Missing MS data, or an MS line with no spectrum behind it.
A truncated chromatogram, or one with no method information.
A lab with no name, address, or reachable contact.
When something looks off, ask for raw LC-MS and UV files, the method SOP or system suitability data, and annotated MS/MS or full spectral printouts. Contact the lab directly to confirm the lot exists in its records. Our COA verification page describes what to request, and our post on verifying COAs and peptide content before ordering shows a worked workflow.
Pro Tip: Save every COA PDF and every verification email in a folder named by lot number. When a result looks odd later, that paper trail is what lets you reproduce or audit the decision.
What is a practical checklist for reviewing a page?
Use this sequence every time. It can catch documentation problems before material reaches your bench.
Match the lot number and test date to the vial and shipment.
Confirm MS or MS/MS identity evidence, with annotated fragments where available.
Confirm the HPLC chromatogram is present, carries a method ID, and supports the stated purity.
Verify net peptide content, and note whether it came from mass balance, amino acid analysis, or qNMR.
Verify the laboratory’s identity, and request raw data or the SOP if anything is unclear.
If any step fails, stop and resolve it before using the material.
How do labs validate identity and purity?
Credible documentation rests on orthogonal methods: no single technique establishes both identity and purity. LC-MS is a central tool for characterizing peptide impurities and structural variants, and systematic LC-MS workflows improve detection and quantitation of product-related variants. Pair that with chromatographic purity and the odds of a false pass drop sharply.
Mass-balance logic. Experts recommend a mass-balance approach when supporting high-purity claims, since HPLC percent purity alone can mislead when counter-ions and water go unaccounted for.
Content assignment. Comparative work on peptide quantification methods found that an HPLC assay against the same peptide bulk showed the lowest inter-laboratory variability, with qNMR and amino acid analysis serving as complementary techniques.
Reference materials. USP and NIST reference standards support value assignment using mass-balance, HPLC, qNMR, and AAA approaches, and robust COAs often cite them.
Method validation. The FDA’s Q2(R2) guidance on validation of analytical procedures expects specificity, precision, accuracy, and detection and quantitation limits to be documented.
Community recommendations on peptide generation, storage, and handling for MS-based assays stress transparent sample preparation, well-characterized internal standards, and stability testing. A COA that reflects those habits is easier to trust.
Why do sequence and modification confirmation matter?
Identity is more than a matching molecular weight. Two different sequences, or a correct sequence with the wrong terminal chemistry, can land on masses close enough to look right at low resolution. A single parent ion tells you the composition is plausible. It does not tell you the residues are in the right order.
MS/MS closes that gap. Fragmentation produces b and y ion series that map onto the sequence, so annotated fragment coverage shows which residues were actually observed. A good page shows the spectrum with labeled fragments, not only a summary line. Gaps in coverage should be visible rather than hidden.
Modifications deserve their own check. N-terminal acetylation adds a defined mass shift, and C-terminal amidation shifts the mass slightly the other way relative to a free acid. If the labeled product is an acetylated or amidated peptide, the documented mass should reflect that, and the MS/MS should localize the change to the terminus. Disulfide bridges, oxidized methionine, deamidation, and truncations also leave signatures. A documentation page that lists the expected modification but shows a mass for the unmodified peptide is a mismatch worth raising with the lab.
When you review a page, compute the expected monoisotopic or average mass for the full labeled structure, modifications included, and compare it with the observed value. Then confirm that the fragment annotation supports the claimed sequence. If you cannot find the annotation, ask for it. Labs that run MS/MS routinely have it on file.
How do you interpret amino acid analysis results?
Amino acid analysis, or AAA, hydrolyzes the peptide into free amino acids and quantifies each one. Its main job on a COA is content: it estimates how much peptide is present, independent of salts and water. It is a content method, not an identity method, and it cannot distinguish residue order.
When AAA appears, check three things. First, do the measured residue ratios match the theoretical composition from the sequence? Ratios should land close to the expected integers, with sensible tolerance. Second, are the amino acids that degrade during acid hydrolysis handled correctly? Tryptophan is largely destroyed, cysteine and methionine need special treatment, and asparagine and glutamine convert to their acids, so a report that ignores these limits deserves scrutiny. Third, is the result expressed as peptide content, and does it reconcile with the other numbers on the page?
That last point is the real test. HPLC purity, net peptide content, and the water and counter-ion figures should hang together. If purity is high but content is low, the balance is salts and water, which is normal for lyophilized peptide. If the numbers cannot be reconciled, ask how content was assigned.
AAA is one of several routes. As noted above, an HPLC assay against the same bulk showed the lowest inter-lab variability, while qNMR and AAA play orthogonal roles. A page that shows two independent content methods agreeing is stronger than one that shows a single number with no stated method.
What should you know about expiration dates and stability data?
An expiration or retest date on a COA is a statement about the lot under defined storage conditions, not a promise about your vial after it leaves controlled storage. Read it as a boundary, and then ask what supports it.
Useful stability information names the storage condition, such as temperature and container, the time points tested, and the attributes monitored. Purity by HPLC over time is the common one, and some programs also track content or specific degradation products. A bare date with no condition attached tells you very little. The community recommendations on peptide handling for MS-based assays put stability testing alongside documentation of sample preparation as a driver of reproducibility, which is the right framing: stability is evidence you can request, not a label you must accept.
Be realistic about what is missing. Real-time data may only cover part of the stated period, and many documents provide none. If your work depends on a defined shelf life, ask what data supports the date and under what conditions it was generated.
Also note the difference between the lot’s date and your own exposure. Time at ambient temperature during shipping, repeated opening, and freeze-thaw cycles all happen after the COA was issued. Record receipt dates and handling events against the lot number so that any later drift in results can be examined against a timeline rather than guessed at.
How do storage and handling affect peptide integrity?
Documentation tells you what the peptide was at release. Storage and handling determine what it is when you use it. A good documentation page states recommended storage conditions, and you should follow them as written, because they come from the lot’s own stability data.
In general terms, lyophilized peptides are kept cold, dry, and protected from light, and they are allowed to reach room temperature in a closed container before opening to limit moisture uptake. Sequences containing methionine, cysteine, or tryptophan are more prone to oxidation, and sequences with asparagine or glutamine can deamidate over time, so those residues are worth knowing about before you plan storage. Moisture is a persistent enemy of lyophilized material, and repeated opening of the same container compounds it.
The practical habits are simple. Keep the container tightly closed, minimize time out of storage, avoid unnecessary freeze-thaw cycles, and label everything with the lot number and date received. Our article on peptide stability, storage, and handling goes deeper on shipping and cold-chain questions. We do not provide dosing, administration, or reconstitution instructions, and nothing here should be read as such. Our focus is keeping a research compound’s documented identity and purity intact until it reaches your experiment.
If the COA gives no storage guidance, treat that as a gap and ask for it before the material is stored under assumptions.
How do you assess regulatory compliance in documentation?
Compliance is easiest to assess by looking for the signs of a quality system rather than a logo. Start with the analytical methods. Documents that follow the logic of the FDA’s Q2(R2) guidance on validation of analytical procedures report specificity, precision, accuracy, and limits of detection and quantitation for the methods behind the numbers. The agency’s guidance on analytical procedures and methods validation for drugs and biologics goes further, stating that apparatus, operating parameters, reagents, and standards should be documented and included in reports or be available on request. That last phrase is your lever: if the COA omits method detail, you are entitled to ask for it.
Next, look at reference standards. Citing USP or NIST materials, as described in the USP reference standards document, shows that values are anchored to recognized materials.
Be careful with claims. A statement that a product is “approved,” “certified,” or “compliant” should name the standard, the issuing body, and the scope, and you should be able to verify it with that body. Research-use-only labeling is a regulatory position in itself, and it means the product is not intended for human or animal consumption. If a document makes a compliance claim you cannot trace to a named standard or an identifiable authority, treat it as unverified until the lab or supplier provides the paperwork.
How can you cross-reference documentation against reviews and outside databases?
A COA should be consistent with everything else you can find about the product. Cross-referencing will not replace the checks above, but it catches mismatches that a single document hides.
Start with internal consistency across the supplier’s own materials. Does the molecular weight on the COA match the product page and the sequence you computed? Does the lab named on the document appear in the supplier’s other batches, with the same format and contact details? A COA whose layout, fonts, or lab details change oddly between lots deserves a question.
Then use independent references. Sequence and mass can be checked against public peptide and protein databases. Published literature on the same compound gives you expected retention behavior and mass values to compare against. Where a supplier’s batch documentation is posted publicly, compare the posted file with the one you received, lot number against lot number.
Customer reviews are weak evidence on their own, but patterns matter. Repeated reports of lot mismatches, missing documents, or unreachable labs are worth weighing. Treat glowing reviews with equal skepticism, since they say little about analytical quality.
Finally, test the contact. Write to the laboratory named on the COA and ask it to confirm the lot. A lab that responds with specifics gives you more assurance than any badge. Our COA verification resource outlines what to ask.
Why transparent COAs matter for reproducible research
We treat the COA as part of the experiment, not an accessory to the invoice. If a result cannot be traced to a verified batch, it cannot be reproduced, and reproducibility is the whole point of laboratory work. That is why we publish batch-level COAs and work with third-party laboratories on HPLC and mass spectrometry verification. When a document lacks method metadata, ask for raw files and the SOP. A supplier worth buying from will answer.
— Adrian K. Solis
Where to find verified research peptides and COAs
We publish COAs and partner with third-party laboratories for HPLC and mass spectrometry verification, so you can check a batch’s documentation before you order. Browse our Research Peptides category for listed products, and use our Research Glossary when you need a term or method explained. If a document you receive raises a question, contact us with the lot number and we will help you trace it. All products are for laboratory research use only, not for human or animal consumption.
FAQ
What are the three most important checks on a peptide COA?
Identity by mass spectrometry, purity by HPLC paired with net peptide content, and a lot number and test date that match your vial. If anyone fails, the document does not support your sample.
Is HPLC percent purity enough to trust a peptide?
No. HPLC purity describes UV-absorbing species in the sample, not water, salts, or counter-ions. Experts recommend a mass-balance approach for high-purity claims, so ask for net peptide content as well.
What should I do if the COA lot number does not match my vial?
Treat the document as not applying to your material. Contact the supplier and the named laboratory, request the correct lot-specific COA, and do not use the material for work that depends on its identity until you have it.
Does a COA prove a peptide is sterile or stable?
No. Sterility, endotoxin, and stability under your conditions are usually not covered unless the document lists a specific test with a method and result. A COA is a snapshot of one lot at release.
What raw data can I ask a laboratory for?
Ask for raw LC-MS and UV files, annotated MS/MS spectra, the method SOP, and system suitability data. The FDA’s guidance on analytical procedures and methods validation says method documentation should be included in reports or available on request.
Sources
Recommended
Comments